- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: NF2 mutated tumors
Total 16145 results
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
Haihe Biopharma Co., Ltd.TerminatedMelanoma | Erdheim-Chester Disease | Non-Small-Cell Lung Cancer | Advanced Tumors | Other RAS/RAF/MEK/ERK Mutated TumorsUnited States, China
-
Novartis PharmaceuticalsCompletedBRAF v600 Mutated Metastatic MelanomaUnited States
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
Idience Co., Ltd.Active, not recruitingSolid Tumors | Homologous Recombination Deficiency | Homologous Recombination Repair Gene MutationKorea, Republic of
-
H. Lee Moffitt Cancer Center and Research InstituteExelixisCompleted
-
Ambrx, Inc.WithdrawnHER2 Mutation-Related Tumors | HER2 Amplified Solid TumorsUnited States
-
PfizerTerminatedDisease ProgressionUnited States, Belgium, France, Argentina, United Kingdom
-
PfizerTerminatedSolid Tumor | Hematologic MalignanciesUnited States
-
Peking University Cancer Hospital & InstituteUnknownPancreatic Cancer | Gastric Adenocarcinoma | Cholangiocarcinoma | HER2-negative Breast CancerChina
-
PfizerTerminatedMetastatic Pancreatic Adenocarcinoma | BRAF Mutated MelanomaUnited States, Australia, Belgium, Canada, France, Italy, Spain, United Kingdom
-
West Cancer CenterAmgen; University of Tennessee Health Science CenterUnknownMelanoma | BRAF Gene MutationUnited States
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
Tocagen Inc.TerminatedMelanoma | Sarcoma | Lymphoma | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Bladder Cancer | Triple Negative Breast Cancer | IDH1 Mutated Solid Tumors | IDH1 Mutated or MGMT Methylated Recurrent HGG (Not Recruiting)United States
-
Center Eugene MarquisCompletedMalignant MelanomaFrance
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedGlioma | Cholangiocarcinoma | ChondrosarcomaNetherlands
-
National Cancer Institute (NCI)TerminatedMelanoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Gastrointestinal CancerUnited States
-
CelgeneTerminatedNeoplasm MetastasisUnited States, Australia
-
Institut du Cancer de Montpellier - Val d'AurelleCompletedMetastatic Colorectal Cancer Patients With KRAS Mutated TumorsFrance
-
National Cancer Institute (NCI)WithdrawnNeoplasms, Nerve Tissue | Peripheral Nervous System Diseases | Heredodegenerative Disorders, Nervous System | Neurofibromatosis 1
-
Manisha ShahNational Comprehensive Cancer NetworkCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Duke UniversityWithdrawn
-
National Center for Tumor Diseases, HeidelbergGerman Cancer Research Center; University Hospital Heidelberg; Neuro-Oncology...Completed
-
The Netherlands Cancer InstituteUnknownMelanoma | Skin NeoplasmsNetherlands
-
Mohammed M MilhemGenentech, Inc.TerminatedMelanoma | Metastatic Melanoma | BRAF-mutated Metastatic Melanoma | V600EBRAF-mutated Metastatic MelanomaUnited States
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
Bristol-Myers SquibbCompleted
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
AbbVieCompletedOncology | High Grade Serous Ovarian Cancer | BRCA Mutated | BRCA Mutated Breast Cancer
-
Hoffmann-La RocheCompletedNeoplasmsAustralia, Spain, Denmark
-
California Pacific Medical Center Research InstitutePfizerWithdrawnMelanomaUnited States
-
Novartis PharmaceuticalsTerminatedPTCH1 or SMO Activated Solid and Hematologic TumorsUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownMelanoma BRAF V600E/K Mutated | CDNKN2A Loss DefinedFrance
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Germany, Singapore, Italy, Australia, Netherlands, Sweden, Spain, Canada, Switzerland, Argentina, Brazil, China
-
Novartis PharmaceuticalsCompletedEndometrial Cancer | VEGF | Solid Tumors and Advanced Endometrial Cancer | Second-line TreatmentItaly, United Kingdom, Spain, Brazil, United States, Korea, Republic of, New Zealand
-
Peking University Cancer Hospital & InstituteUnknown
-
University of MiamiMedtronicNot yet recruiting
-
BeiGeneNot yet recruitingMetastatic Solid Tumor | Advanced Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma | Alpha-fetoprotein (AFP)-Producing Gastric Cancer | Extragonadal Yolk Sac Tumors | Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer
-
Sichuan Kelun Pharmaceutical Research Institute...Not yet recruitingAdvanced Solid Tumors
-
National Cancer Institute (NCI)Not yet recruitingPheochromocytoma | Somatostatin Receptor Positive | Paragangliomas | Gastrointestinal Neuroendocrine TumorsUnited States
-
Tongji HospitalNot yet recruiting
-
Changhai HospitalRecruiting
-
Georgiamune IncNot yet recruitingSolid Tumor | Melanoma Stage IV
-
Seoul National University HospitalRecruitingLiver Malignant TumorsKorea, Republic of
-
Innolake BiopharmNot yet recruitingAdvanced Solid Tumor
-
Peking University Cancer Hospital & InstituteNot yet recruitingMelanoma | Metastatic Melanoma | Mucosal MelanomaChina
-
Eye & ENT Hospital of Fudan UniversityThe Eye Hospital of Wenzhou Medical UniversityNot yet recruitingRetinoblastoma | Refractory
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...Not yet recruitingAdvanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma)China
-
BeiGeneNot yet recruiting